CompletedNCT01948895
Desvenlafaxine Treatment for Persistent Depressive Disorder
About this title
Read the official source — NCT01948895Medication studyAges 18–65CanadaPTSD
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Mississauga and 1 more locationSee all locations and recruitment
Study information
Study start dateAugust 2012
- Recruitment status
- Completed
- Enrollment listed in the registry
- 30
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT01948895
- Official title
Show the full official title
An 8-week Open-Label Flexible-Dose Study Of Desvenlafaxine as Monotherapy In The Treatment Of Dysthymia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Mississauga · Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Desvenlafaxine.
Who was this study for?
Listed age limits: 18 years to 65 years.
